KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) Invested Capital (2016 - 2025)

Historic Invested Capital for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $85.7 billion.

  • Johnson & Johnson's Invested Capital rose 1480.03% to $85.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $85.7 billion, marking a year-over-year increase of 1480.03%. This contributed to the annual value of $103.9 billion for FY2024, which is 807.91% up from last year.
  • According to the latest figures from Q3 2025, Johnson & Johnson's Invested Capital is $85.7 billion, which was up 1480.03% from $90.0 billion recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's Invested Capital ranged from a high of $106.1 billion in Q1 2022 and a low of $69.2 billion during Q2 2021
  • Moreover, its 5-year median value for Invested Capital was $83.5 billion (2024), whereas its average is $85.9 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 1156.81% in 2024, then surged by 1710.07% in 2025.
  • Johnson & Johnson's Invested Capital (Quarter) stood at $74.1 billion in 2021, then rose by 6.69% to $79.0 billion in 2022, then grew by 21.64% to $96.1 billion in 2023, then increased by 8.08% to $103.9 billion in 2024, then dropped by 17.54% to $85.7 billion in 2025.
  • Its Invested Capital was $85.7 billion in Q3 2025, compared to $90.0 billion in Q2 2025 and $92.0 billion in Q1 2025.